Microangiopathic hemolytic anemia associated with metastatic breast carcinoma
โ Scribed by Ataga, Kenneth I.; Graham, Mark L.
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 618 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A 68year-old man was treated with FAM (5-mise 6 months later. At necropsy, minimal fluorouracil, doxorubicin [Adriamycin], mito-residual cancer and severe pulmonary venomycin-C) for metastic gastric adenocarci-occlusive disease was found. Pulmonary venonoma. Twelve months later while in complete occ
Two patients with epidermoid carcinoma treated with mitomycin-C (Mit-C) and 5-fluorouracil (5-FU) developed microangiopathic hemolytic anemia (MAHA), renal failure, and altered mental status. Patient 1 was free of metastatic disease, on maintenance Mit-C and 5-FU when MAHA changes appeared. Patient
Intravenous immunoglobulin (IVIg) is a useful tool in the treatment of a variety of neuromuscular disorders. Though IVIg therapy is generally safe, hemolytic anemia is a potentially serious complication that is often overlooked, and is currently not listed in product inserts. We analyzed 45 patients